Cargando…
Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial
BACKGROUND: Mentor MemoryGel Xtra breast implants (Mentor Worldwide LLC, Irvine, CA) were designed to maintain the soft, natural feel of MemoryGel implants while increasing fullness and projection and minimizing wrinkling, rippling, and related complications through optimization of shell gel-fill. O...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653354/ https://www.ncbi.nlm.nih.gov/pubmed/37610252 http://dx.doi.org/10.1093/asj/sjad272 |
_version_ | 1785136393373089792 |
---|---|
author | Alderman, Amy Caplin, David Hammond, Dennis C Keane, Alexandra Turetzky, Jay Kane, William J |
author_facet | Alderman, Amy Caplin, David Hammond, Dennis C Keane, Alexandra Turetzky, Jay Kane, William J |
author_sort | Alderman, Amy |
collection | PubMed |
description | BACKGROUND: Mentor MemoryGel Xtra breast implants (Mentor Worldwide LLC, Irvine, CA) were designed to maintain the soft, natural feel of MemoryGel implants while increasing fullness and projection and minimizing wrinkling, rippling, and related complications through optimization of shell gel-fill. OBJECTIVES: To measure 3-year safety and effectiveness of MemoryGel Xtra breast implants in the Mentor MemoryGel and MemoryShape Combined Cohort Clinical Study. METHODS: Participants were implanted with MemoryGel Xtra breast implants in a prospective, multicenter clinical trial. Rates of complications and reoperations were analyzed to assess device safety and BREAST-Q was employed to assess device effectiveness. RESULTS: Two hundred eighty-seven females receiving MemoryGel Xtra breast implants were enrolled. Complication rates in the primary augmentation cohort included rates of 1.5% for implant-related reoperation, 2.3% for explantation, and 1.5% for Baker grade III or IV capsular contracture. For the revisional augmentation cohort, these rates were 2.8% for implant-related reoperation, 4.3% for explantation, and 3.0% for capsular contracture. For the primary reconstruction cohort, these rates were 12.0% for implant-related reoperation, 12.3% for explantation, and 7.3% for capsular contracture. For the revisional reconstruction cohort, these rates were 7.1% for capsular contracture, with zero implant-related reoperations or explantations. There were no reports of infection or implant malposition or displacement in any of these cohorts. Each cohort showed significantly improved satisfaction with breasts and psychosocial and sexual well-being at 1 year following the primary procedure. CONCLUSIONS: These data are consistent with legacy clinical data for MemoryGel and provide the first published safety and effectiveness data regarding the use of MemoryGel Xtra breast implants for breast augmentation and reconstruction. LEVEL OF EVIDENCE: 4: [Image: see text] |
format | Online Article Text |
id | pubmed-10653354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106533542023-08-23 Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial Alderman, Amy Caplin, David Hammond, Dennis C Keane, Alexandra Turetzky, Jay Kane, William J Aesthet Surg J Original Article BACKGROUND: Mentor MemoryGel Xtra breast implants (Mentor Worldwide LLC, Irvine, CA) were designed to maintain the soft, natural feel of MemoryGel implants while increasing fullness and projection and minimizing wrinkling, rippling, and related complications through optimization of shell gel-fill. OBJECTIVES: To measure 3-year safety and effectiveness of MemoryGel Xtra breast implants in the Mentor MemoryGel and MemoryShape Combined Cohort Clinical Study. METHODS: Participants were implanted with MemoryGel Xtra breast implants in a prospective, multicenter clinical trial. Rates of complications and reoperations were analyzed to assess device safety and BREAST-Q was employed to assess device effectiveness. RESULTS: Two hundred eighty-seven females receiving MemoryGel Xtra breast implants were enrolled. Complication rates in the primary augmentation cohort included rates of 1.5% for implant-related reoperation, 2.3% for explantation, and 1.5% for Baker grade III or IV capsular contracture. For the revisional augmentation cohort, these rates were 2.8% for implant-related reoperation, 4.3% for explantation, and 3.0% for capsular contracture. For the primary reconstruction cohort, these rates were 12.0% for implant-related reoperation, 12.3% for explantation, and 7.3% for capsular contracture. For the revisional reconstruction cohort, these rates were 7.1% for capsular contracture, with zero implant-related reoperations or explantations. There were no reports of infection or implant malposition or displacement in any of these cohorts. Each cohort showed significantly improved satisfaction with breasts and psychosocial and sexual well-being at 1 year following the primary procedure. CONCLUSIONS: These data are consistent with legacy clinical data for MemoryGel and provide the first published safety and effectiveness data regarding the use of MemoryGel Xtra breast implants for breast augmentation and reconstruction. LEVEL OF EVIDENCE: 4: [Image: see text] Oxford University Press 2023-08-23 /pmc/articles/PMC10653354/ /pubmed/37610252 http://dx.doi.org/10.1093/asj/sjad272 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of The Aesthetic Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Alderman, Amy Caplin, David Hammond, Dennis C Keane, Alexandra Turetzky, Jay Kane, William J Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial |
title | Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial |
title_full | Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial |
title_fullStr | Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial |
title_full_unstemmed | Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial |
title_short | Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial |
title_sort | clinical results of mentor memorygel xtra breast implants from the glow clinical trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653354/ https://www.ncbi.nlm.nih.gov/pubmed/37610252 http://dx.doi.org/10.1093/asj/sjad272 |
work_keys_str_mv | AT aldermanamy clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial AT caplindavid clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial AT hammonddennisc clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial AT keanealexandra clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial AT turetzkyjay clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial AT kanewilliamj clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial |